Patient perspectives on research gaps in cluster headache
Headache: The Journal of Head and Face Pain · 2026-02 · 66 (2) · 377-387
DOI: 10.1111/head.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 21.01.2026. Verfasst von Faraidoon Haghdoost und 17 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Cluster Headache, Biomedical Research. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
This study was undertaken to identify gaps in cluster headache management, highlight patient‐prioritized research needs, and assess patient interest in, and preferences for, clinical trial participation.
Background
Many people with cluster headache still lack effective treatment options to control or prevent attacks. There is a critical need for more studies, particularly clinical trials, in this field. To design and conduct successful trials, it is essential to identify priority research areas, allocate resources effectively, and ensure patient engagement and support.
Methods
This study was an online survey conducted among Australian adults with self‐reported cluster headache. Participants were recruited using a multi‐channel approach, including direct outreach by clinicians, support from patient advocacy groups, and broad social media distribution. It collected data on demographics, treatment experiences, and perspectives on future research, including research priorities, and preferred outcomes and interventions. Additionally, participants' interest in joining clinical trials was assessed to help identify potential candidates for future studies.
Results
Of the 219 individuals who began the survey, 17 (8%) were excluded due to providing no responses beyond demographic data or reporting no cluster headache diagnosis by a healthcare professional. The final sample consisted of 202 participants, with an average age of 46 years, 77% aged 25–54 years, 55% male, 72% had been living with cluster headache for more than 10 years, and 29% reported attacks occurring almost every month throughout the year. A quarter of participants had not followed up with a healthcare provider for cluster headache management when they completed the survey. Among those who sought care ( n = 145 [72%]), general practitioners were the most frequently consulted (86%), followed by neurologists (66%). Treatments were considered “not at all effective” or “somewhat ineffective” by 35% of all participants, while 27% reported only partial effectiveness. The main treatment challenges were ineffectiveness (74%), side effects (54%), cost (53%), and difficulties with access (39%). Among the 202 participants, 126 (62%) indicated interest in participating in future cluster headache trials, while 26 (13%) responded with “maybe.” Psilocybin was the highest‐ranked treatment in terms of participants who were “very interested,” with 66% selecting this option. The combined proportion of participants who were “very interested” or “interested” was 84% for combination therapies, 82% for psilocybin, 71% for medical devices, and 66% for anti‐CGRP treatments.
Conclusion
Participants with reported cluster headache highlighted inadequate treatment options, emphasized the need for further research, and expressed interest in future clinical trials, particularly those involving psilocybin or combination therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
- Migraine Foundation, Western Health, Footscray, Victoria, Australia.
- Department of Neurology, University of Copenhagen, Rigshospitalet-Glostrup, Danish Headache Center, Glostrup, Denmark.
- Migraine & Headache Australia, Australia.
- Department of Neurology, St Vincent's Private Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Rigmor H Jensen, Cheryl Carcel, Anja Sofie Petersen
Zitieren
APA
Haghdoost, F., Bahceci, D., Delcourt, C., Wijeratne, T., Jensen, R. H., Cincinnato, C., Tomlinson, S., Wold, B., Polito, V., Carcel, C., Ashraf, U., Jenkins, B., Petersen, A. S., Ray, J. C., Schindler, E. A. D., Tsang, B., Gianacas, C., & Rodgers, A. (2026). Patient perspectives on research gaps in cluster headache. Headache: The Journal of Head and Face Pain, 66(2), 377-387. https://doi.org/10.1111/head.70031
Vancouver
Haghdoost F, Bahceci D, Delcourt C, Wijeratne T, Jensen RH, Cincinnato C, et al. Patient perspectives on research gaps in cluster headache. Headache: The Journal of Head and Face Pain. 2026;66(2):377-387. doi:10.1111/head.70031
BibTeX
@article{Haghdoost2026,
author = {Haghdoost, Faraidoon and Bahceci, Dilara and Delcourt, Candice and Wijeratne, Tissa and Jensen, Rigmor H and Cincinnato, Carl and Tomlinson, Susan and Wold, Bob and Polito, Vince and Carcel, Cheryl and Ashraf, Usman and Jenkins, Bronwyn and Petersen, Anja Sofie and Ray, Jason C and Schindler, Emmanuelle A D and Tsang, Benjamin and Gianacas, Chris and Rodgers, Anthony},
title = {Patient perspectives on research gaps in cluster headache},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
volume = {66},
number = {2},
pages = {377--387},
doi = {10.1111/head.70031}
}
EUVIMED